A carregar...
Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Apixaban, an inhibitor of direct factor Xa, is used for the treatment of venous thromboembolic events or prevention of stroke. Unlike many other anticoagulant agents, it does not need periodic monitoring. However, monitoring is still required to determine the risk of bleeding due to overdose or surg...
Na minha lista:
| Publicado no: | Transl Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Clinical Pharmacology and Therapeutics
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989270/ https://ncbi.nlm.nih.gov/pubmed/32055579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2019.27.1.33 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|